AstraZeneca's IFRS net income for 3 months of 2022 was $0.388 billion, down four times from $1.562 billion in the previous year. Revenue increased by 55.6% to $11.39 billion compared to $7.32 billion a year earlier.
AstraZeneca's IFRS net income for 3 months of 2022 was $0.388 billion, down four times from $1.562 billion in the previous year. Revenue increased by 55.6% to $11.39 billion compared to $7.32 billion a year earlier. 
astrazeneca.com
English (US) 